A lot of "buzz"on the various Alzheimer's News websites on this subject. Check it out for youself. Could this be what we have all been looking for? One can only hope and pray. DickS
Thank you so much for bringing this article to our attention. I typed in Enbrel and Alzheimers Disease on Google and got page after page on this article. The info was released by the Univ. of Arkansas for Medical Science yesterday at around 10 AM. If you go into the web site for the Univ of Arkansas for Medical Science (UAMS), there are phone numbers listed to call for more info and also e-mail addresses. It looks like to me that a person named Andrea Peel released this article. They list her e-mail address as: Andrea@uams.edu They also list an email address for: Leslie W. Taylor: Leslie@uams.edu
All of this info is on the web site for Univ. of Arkansas. (UAMS)
Before I take any of this to my DH's doctor, I am going to contact the UAMS and try to find out more about this study and also the time frame of when they think this might be available and if they think it will become available. I showed one of the doctors tonight that was at the NH the article and he had no idea what the study was and has not heard of it. So I think I will try to go to the source of the article and find out more details and see if I cannot get some kind of a time frame, if they even have one.
Even if this drug treatment is successful and I hope it is .... today the Supreme Court made a ruling that terminally ill patients have no constitutional right to be treated with experimental drugs. At the snails pace that the FDA works I find that depressing and fustrating.
Yes, it is approved for arthritis. It is very expensive, so you might have a problem with insurance paying for it. We all have arthritis, right? It is already approved so it might not take as long.
Its approved for psoriasis first, then for arthritis. Problem for our current AD population is only that it isn't approved for this disease (the AD) or the route it needs to be delivered (intraspinal).